Literature DB >> 17455084

A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: analysis of mouse specific and human antibodies cross-reactive with murine tissue.

Sandra Kunder1, Julia Calzada-Wack, Gabriele Hölzlwimmer, Jacqueline Müller, Claudia Kloss, Will Howat, Jörg Schmidt, Heinz Höfler, Madhuri Warren, Leticia Quintanilla-Martinez.   

Abstract

Immunohistochemistry is an indispensable tool in human pathology enabling immunophenotypic characterization of tumor cells. Immunohistochemical analyses of mouse models of human hematopoietic neoplasias have become an important aspect for comparison of murine entities with their human counterparts. The aim of this study was to establish a diagnostic antibody panel for analysis of murine lymphomas/leukemias, useful in formalin-fixed/paraffin-embedded tissue. Overall, 48 antibodies (4 rabbit monoclonal, 12 rabbit polyclonal, 2 goat polyclonal, 11 rat, and 19 mouse monoclonal), which were either mouse-specific (14) or cross-reactive with murine tissue (34) were tested for staining quality and diagnostic value in 468 murine hematopoietic neoplasms. Specific staining was achieved with 29 antibodies, of which 18 were human antibodies cross-reactive with murine tissue. Only 23 (B220, BCL-2, BCL-6, CD117, CD138 (2x), CD3 (2x), CD43, CD45, CD5, CD79 alpha cy, cyclin D1, Ki-67 (2x), Mac-3, Mac-2, lysozyme, mast cell tryptase, MPO, Pax-5, TdT, and TER-119) were regarded as valuable for diagnostic evaluation. Immunohistochemistry was also established in an automated immunostainer for high throughput analysis. The antibody panel developed is useful for the classification of murine lymphomas and leukemias analyzed, and a valuable tool for human and veterinary pathologists involved in the diagnostic interpretation of murine models of hematopoietic neoplasias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17455084     DOI: 10.1080/01926230701230296

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  14 in total

1.  The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.

Authors:  K S Bommert; M Effenberger; E Leich; M Küspert; D Murphy; C Langer; R Moll; S Janz; A Mottok; S Weissbach; A Rosenwald; R Bargou; K Bommert
Journal:  Leukemia       Date:  2012-07-09       Impact factor: 11.528

Review 2.  Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.

Authors:  Jerrold M Ward; Jerold E Rehg; Herbert C Morse
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

3.  Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.

Authors:  Lingyan Wu; Cong Yan; Magdalena Czader; Oded Foreman; Janice S Blum; Reuben Kapur; Hong Du
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

Review 4.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

5.  Mast cells and inflammation-associated colorectal carcinogenesis.

Authors:  Takuji Tanaka; Hideki Ishikawa
Journal:  Semin Immunopathol       Date:  2012-09-20       Impact factor: 9.623

6.  Cutaneous B-cell lymphoma in a Perdido Key Beach mouse (Peromyscus poliontus trissyllepsis).

Authors:  Copper Aitken-Palmer; Matti Kiupel; Kathy Russell; Linda Hayes; Darryl Heard
Journal:  Comp Med       Date:  2012-04       Impact factor: 0.982

7.  T-helper-1-cell cytokines drive cancer into senescence.

Authors:  Heidi Braumüller; Thomas Wieder; Ellen Brenner; Sonja Aßmann; Matthias Hahn; Mohammed Alkhaled; Karin Schilbach; Frank Essmann; Manfred Kneilling; Christoph Griessinger; Felicia Ranta; Susanne Ullrich; Ralph Mocikat; Kilian Braungart; Tarun Mehra; Birgit Fehrenbacher; Julia Berdel; Heike Niessner; Friedegund Meier; Maries van den Broek; Hans-Ulrich Häring; Rupert Handgretinger; Leticia Quintanilla-Martinez; Falko Fend; Marina Pesic; Jürgen Bauer; Lars Zender; Martin Schaller; Klaus Schulze-Osthoff; Martin Röcken
Journal:  Nature       Date:  2013-02-03       Impact factor: 49.962

8.  Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.

Authors:  Paolo Sportoletti; Silvia Grisendi; Samia M Majid; Ke Cheng; John G Clohessy; Agnes Viale; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Blood       Date:  2008-01-22       Impact factor: 22.113

9.  Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma.

Authors:  Chang-Lung Lee; Katherine D Castle; Everett J Moding; Jordan M Blum; Nerissa Williams; Lixia Luo; Yan Ma; Luke B Borst; Yongbaek Kim; David G Kirsch
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

10.  Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice.

Authors:  Silke H Raffegerst; Gabriele Hoelzlwimmer; Sandra Kunder; Josef Mysliwietz; Leticia Quintanilla-Martinez; Dolores J Schendel
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.